Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • AYUSH
    • Ministry of AYUSH...

    Ministry of AYUSH develops drugs for Dengue, Cancer

    Written by Ruby Khatun Khatun Published On 2017-08-11T09:18:35+05:30  |  Updated On 11 Aug 2017 9:18 AM IST
    Ministry of AYUSH develops drugs for Dengue, Cancer

    New Delhi: The Ministry of Ayurveda, Unani, Siddha and Homeopathy (AYUSH) has developed drugs for Dengue, cancer, migrain and asthma, the Rajya Sabha was informed by Shri Shripad Yesso Naik.


    The Research Councils including the Central Council for Research in Ayurvedic Science (CCRAS), the Central Council for Research in Unani Medicine (CCRUM), Central Council for Research in Siddha (CCRS), Central Council for Research in Homeopathy (CCRH) and autonomous bodies under the Ministry of AYUSH are engaged in Research and Development of new drugs.


    The developed drugs are effective against diseases like Geriatric Health, Bronchial Asthma, Diabetes Mellitus, wound healing, Lymphatic Filariasis, Dengue, Ovarian Cancer, Migrain, Fibroid Uterus, Constipation, Rheumatoid Arthritis ,Abdominal Worm and Urolithiasis.


    The details of new drugs developed by the Research Councils after clinical trials are as under: -


    CCRAS:-




    • AYUSH Rasayan A & B for geriatric health

    • AYUSH A for Bronchial Asthma

    • AYUSH-D for Diabetes Mellitus

    • C1 oil for wound healing

    • AYUSH-SL for Lymphatic Filariasis

    • PJ-7 for dengue

    • Carctol-S for Ovarian Cancer

    • AYUSH M-3 for Migrain


    CCRH:-




    • Coleus forskohlii

    • Catheranthus roseus

    • Buxus sempervirens

    • Cynara scolymus

    • Hygrophilla spinosa

    • Persea Americana


    CCRS:-




    • D5 chooranam for Diabetes mellitus,

    • Rasagandhi mezhugu for Fibroid uterus,

    • Sirupeelaiyathi Kudineer in Kalladaippu (Urolithiasis)


    CCRUM:-




    • Z. N. 5:- A herbal composition against bronchial asthma and process for preparation thereof.

    • Cap. Habis:- A herbal composition effective against nazfuddam and a process for the preparation thereof.

    • Cap. Mubarak:- A novel herbal composition effective as anti pyretic and to a process for the preparation thereof.

    • Cap. Nazla:- A novel herbal composition effective against coryza and a process for preparing thereof.

    • Qurs. Mafasil:- A novel herbal composition (sugar coated) effective against rheumatoid arthritis.

    • Cap. Hudar:- A herbal composition effective against arthritis and to process for the preparation thereof.

    • Qurs. Mulaiyin:- A novel herbal composition and a process for preparation thereof effective against constipation.

    • Cap. Deedan:- A Novel Herbal Composition And A Process For Preparation Thereof Effective Against Abdominal Worm.


    Read also: Government commercialised ayurvedic medicines for diabetes, arthritis
    asthmacancerDenguedevelopsDiabetes mellitusdrugsGeriatric HealthLymphatic FilariasismigrainMinistry of Ayushovarian cancerRajya Sabharheumatoid arthritisShripad Yesso Naik
    Source : PRESS RELEASE

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok